FTSE 100 Poised to Extend Gains Despite AstraZeneca Vaccine Concerns

Posted April 8th, 2021 by BonTrade and filed in BonTrade News

The UK benchmark FTSE 100 may shrug aside concerns regarding the AstraZeneca coronavirus vaccine and push to fresh post-crisis highs, on the back of swelling optimism as Britain progresses to the n…

See more here:
FTSE 100 Poised to Extend Gains Despite AstraZeneca Vaccine Concerns

Leave a Reply

You must be logged in to post a comment.